40 Results for "

glucocerebrosidase

" in MedChemExpress (MCE) Product Catalog:
Products (40)

40 Results for "glucocerebrosidase" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-B1039A
CAS No.: 23828-92-4
Synonyms: NA-872 hydrochloride
Ambroxol hydrochloride (NA-872 hydrochloride), an active metabolite of the proagent Bromhexine, has potent expectorant effects. Ambroxol hydrochloride is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol hydrochloride induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B1039
CAS No.: 18683-91-5
Synonyms: NA-872
Ambroxol (NA-872), an active metabolite of the proagent Bromhexine, has potent expectorant effects. Ambroxol is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N7745
CAS No.: 52050-17-6
Synonyms: Glucopsychosine; Lyso-Gb1; Lyso-GL1
Glucosylsphingosine (lyso-Gb1) is a deacylated form of glucosylceramide with neurotoxicity and is also a noncompetitively inhibitor of glucocerebrosidase with a Ki value of 30 μM. Glucosylsphingosine is promising for research of Krabbe and Gaucher disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-120034
CAS No.: 1462267-07-7
Purity:  99.53%
NCGC 607 is a noninhibitory small-molecule chaperone of glucocerebrosidase (GCase). NCGC 607 can increase GCase activity, reduce α-synuclein levels, and decrease glycolipid levels. NCGC 607 can be used in the research of Gaucher disease and Parkinson's disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P75786
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: GBA1; Acid Beta-Glucosidase; Prev. GLUC; glucocerebrosidase; Prev. GBA; Glucosylceramidase; D-Glucosyl-N-Acylsphingosine Glucohydrolase; Imiglucerase; Lysosomal Cholesterol Glycosyltransferase; Alglucerase; Lysosomal Acid Glucosylceramidase; Beta-GC; Chol
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-139452
CAS No.: 209540-62-5
Purity:  99.96%
Target:  

Glycosidase

Research Areas:  

Others

PFB-FDGlu is a selective lysosomal Glucocerebrosidase (GCase) substrate, which is metabolised by GCase to yield fluorescein. PFB-FDGlu is cell permeable and can be used with a flow cytometer to measure GCase activity in living cells on a single-cell basis .
loading...
    loading...
Cat. No.: HY-147976
CAS No.: 2279945-76-3
Target:  

Glycosidase

Glucocerebrosidase-IN-1 (compound 11a) is a potent and selective GCase (glucocerebrosidase) inhibitor, with an IC50 of 29.3 μM and a Ki of 18.5 μM. Glucocerebrosidase-IN-1 can be used for the research of Gaucher disease (GD) and Parkinson’s disease (PD) .
loading...
    loading...
Cat. No.: HY-104038
CAS No.: 1919820-28-2
Purity:  99.11%
Synonyms: LTI-291; BIA 28-6156
Target:  

Glycosidase

Research Areas:  

Neurological Disease Endocrinology

Pariceract (LTI-291) is an activator of glucocerebrosidase (Gcase), with activation rates of more than 60% (1 μM) and between 10%-20% (0.1 μM). Pariceract can be used for Parkinson's disease and endometriosis research .
loading...
    loading...
Cat. No.: HY-170035
CAS No.: 95119-86-1
Synonyms: C18 Glucosyl(β) ceramide (d18:1/18:0); D-glucosyl-β-1,1' N-stearoyl-D-erythro-sphingosine
Target:  

Fungal Wnt β-catenin

Research Areas:  

Infection Neurological Disease Cancer

GlcCer (d18:1/18:0) (C18 Glucosyl(β) ceramide (d18:1/18:0)) is a glycosphingolipids that activates the Wnt/β-catenin pathway by targeting LRP6. GlcCer (d18:1/18:0) drives EMT, migration, invasion and GBA1-mediated liver cancer metastasis. GlcCer (d18:1/18:0) accumulates to impair lysosomal function and induce toxic α-synuclein aggregation. GlcCer (d18:1/18:0) supports growth, sporulation, germination and virulence in Penicillium digitatum. GlcCer (d18:1/18:0) is reduced in demyelinated mouse corpus callosum. GlcCer (d18:1/18:0) can be used for the research of liver cancer, synucleinopathies, fungal, Parkinson’s disease and Gaucher disease .
loading...
    loading...
Cat. No.: HY-117861
CAS No.: 1380716-06-2
Purity:  ≥98.0%
Target:  

Glycosidase

Research Areas:  

Metabolic Disease

ML198 is a glucocerebrosidase (GCase) modulator with an EC50 of 0.4 μM. ML198 is an activator and non-inhibitory chaperone of glucocerebrosidase. ML198 can be used for the research of Gaucher disease . ML198 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-B1039AS
CAS No.: 2741380-71-0
Synonyms: NA-872-d5 hydrochloride
Ambroxol-d5 (hydrochloride) is the deuterium labeled Ambroxol hydrochloride. Ambroxol hydrochloride (NA-872 hydrochloride), an active metabolite of the proagent Bromhexine, has potent expectorant effects. Ambroxol hydrochloride is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol hydrochloride induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research .
loading...
    loading...
Cat. No.: HY-154823
CAS No.: 2759897-35-1
Purity:  99.23%
Target:  

Glycosidase

Research Areas:  

Metabolic Disease

Gcase activator 2 (compound 14), a pyrrolo[2,3-b]pyrazine, is alos a β-Glucocerebrosidase (GCase) activator (EC50=3.8 μM). Gcase activator 2 induces GCase dimerizatio (both K-type and V-type). And Gcase activator 2 has low metabolic clearance in human and mouse .
loading...
    loading...
Cat. No.: HY-114043
CAS No.: 442898-34-2
Purity:  99.54%
Target:  

Glycosidase

Research Areas:  

Metabolic Disease

NCGC00092410 is a potent, selective, and nonsugar glucocerebrosidase (GC) inhibitor, with an IC50 of 31 nM. NCGC00092410 shows no activity against the related hydrolases at concentrations up to 77 μM. NCGC00092410, a GC chaperone, and increases the activity and lysosomal localization of glucocerebrosidase in mutant cell lines. NCGC00092410 can be used for the research of Gaucher disease .
loading...
    loading...
Cat. No.: HY-B1039AR
CAS No.: 23828-92-4
Synonyms: NA-872 hydrochloride (Standard)
Ambroxol (hydrochloride) (Standard) is the analytical standard of Ambroxol (hydrochloride). This product is intended for research and analytical applications. Ambroxol hydrochloride (NA-872 hydrochloride), an active metabolite of the proagent Bromhexine, has potent expectorant effects. Ambroxol hydrochloride is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol hydrochloride induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research .
loading...
    loading...
Cat. No.: HY-160426
CAS No.: 2270984-21-7
Target:  

Glycosidase

Research Areas:  

Neurological Disease

Gcase activator 3 is a β-glucocerebrosidase (GCase) activator with an EC50 of 1.49 μM. By binding to the allosteric site of GCase, Gcase activator 3 partially stabilizes GCase and enhances its activity. Gcase activator 3 can be conjugated with fluorophores to form fluorescent probes, which are used for high-throughput screening of GCase. Gcase activator 3 is applicable to research related to Gaucher's disease, Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy .
loading...
    loading...
Cat. No.: HY-163779
CAS No.: 3080715-77-8
Target:  

Glycosidase

Research Areas:  

Neurological Disease

β-Glucocerebrosidase modulator 1 (Compound 28) is an allosteric modulator for β-Glucocerebrosidase with an EC50 of 9.0 μM and a Kd of 0.050 μM .
loading...
    loading...
Cat. No.: HY-147976A
CAS No.: 2279945-77-4
Target:  

Glycosidase

Research Areas:  

Neurological Disease

Glucocerebrosidase-IN-1 (compound 11a) hydrochloride is a potent and selective GCase (glucocerebrosidase) inhibitor, with an IC50 of 29.3 μM and a Ki of 18.5 μM. Glucocerebrosidase-IN-1 hydrochloride can be used for the research of Gaucher disease (GD) and Parkinson’s disease (PD) .
loading...
    loading...
Cat. No.: HY-D1461
CAS No.: 129787-66-2
Fluorescein Di-β-D-Glucopyranoside is a specific β-glucocerebrosidase substrate that can be used for the intralysosomal β-galactosidase .
loading...
    loading...
Cat. No.: HY-B1039C
CAS No.: 96989-76-3
Synonyms: NA-872 acefylline; Acebrophylline
Ambroxol (NA-872) acefylline, an active metabolite of the proagent Bromhexine, has potent expectorant effects. Ambroxol acefylline is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol acefylline induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research .
loading...
    loading...
Cat. No.: HY-A0058
CAS No.: 136778-12-6
Synonyms: Retinyl β-D-glucoside
Target:  

Glycosidase

Research Areas:  

Metabolic Disease

Retinyl glucoside (Retinyl β-D-glucoside) is a lipid β-D-glucoside of retinol, and also serves as a substrate for broad-spectrum β-glucosidase (β-glucosidase). Retinyl glucoside can be hydrolyzed by guinea pig hepatocyte cytosolic and membrane-associated β-glucosidases as well as almond β-glucosidase to release retinol and glucose, but it is not hydrolyzed by human placental glucocerebrosidase. Retinyl glucoside can be used in the research of Gaucher's disease .
loading...
    loading...